VistaGen Therapeutics, Inc.VTGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
96.66%
↑ 95% above average
Average (9y)
49.49%
Historical baseline
Range
High:196.90%
Low:-54.88%
CAGR
+5.1%
Consistent expansion
| Period | Value |
|---|---|
| 2025 | 96.66% |
| 2024 | -54.88% |
| 2023 | 25.33% |
| 2022 | 196.90% |
| 2021 | -10.50% |
| 2020 | -22.07% |
| 2019 | 120.27% |
| 2018 | 49.17% |
| 2017 | 32.36% |
| 2016 | 61.61% |